Article
Integration of microarray technology into prenatal diagnosis: counselling issues generated during the NICHD clinical trial
30 Mar 2012
Abstract excerpt
Cytogenetic microarray analysis (CMA) in prenatal testing detects chromosome abnormalities and new genetic syndromes that would be missed by conventional cytogenetics and has the potential to significantly enhance prenatal genetic evaluation. A large Eunice Kennedy Shriver National Institute Of Child Health and Human Development (NICHD)-sponsored multicentered trial to assess the role of CMA as a primary prenatal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
